Cefixime-induced Oromandibular Dystonia in an Adult: A Case Report

Lisa Mondet1, Fanny Radoubé1, Valérie Gras2

  • 1Régional Pharmacovigilance Centre, Amiens University Hospital, Amiens,France.

Current Drug Safety
|March 16, 2017
PubMed
Abstract

Insights

Cefixime, a third-generation cephalosporin, can cause oromandibular dystonia, a rare side effect. This case highlights the potential for involuntary muscle contractions with cefixime, even if not listed in its product characteristics.

Area of Science:

  • Pharmacology
  • Neurology
  • Infectious Diseases

Background:

  • Cefixime, a third-generation cephalosporin antibiotic, is widely used for various infections.
  • While generally well-tolerated, cefixime can cause side effects, including digestive issues, and potentially unlisted adverse events.
  • Oromandibular dystonia is a movement disorder characterized by involuntary muscle contractions in the jaw, tongue, and face.

Purpose of the Study:

  • To report a case of recurrent acute oromandibular dystonia in an adult patient treated with cefixime.
  • To highlight a potential, albeit rare, neurological side effect of cefixime not typically listed in its product information.
  • To contribute to the understanding of cefixime's potential adverse effects beyond common gastrointestinal disturbances.

Main Methods:

  • A case report detailing an adult patient's experience with cefixime.
  • Documentation of the onset, recurrence, and resolution of oromandibular dystonia symptoms.
  • Neurological confirmation of the acute oromandibular dystonia diagnosis.

Main Results:

  • The patient experienced recurrent episodes of acute oromandibular dystonia after each dose of cefixime.
  • Symptoms resolved completely upon discontinuation of the cefixime treatment.
  • The diagnosis was confirmed by a neurologist, establishing a clear link between cefixime and the dystonic episodes.

Conclusions:

  • Dystonia, including oromandibular dystonia, has been associated with other beta-lactam antibiotics and rarely with cefixime, particularly in pediatric cases.
  • Potential mechanisms involve neurotransmitter pathways, including dopamine, acetylcholine, and GABA.
  • Clinicians should consider cefixime and other beta-lactam antibiotics as potential causes of dystonia, even if not listed as a known side effect in the Summary of Product Characteristics.

Related Concept Videos